Metastatic prostatic adenocarcinoma presenting as a pituitary mass: Shrinkage of the lesion and clinical improvement with medical treatment

Prostate

Volumn 32, Issue 4, 1997, Pages 241-245

  Losa, Marco ^a,b   Grasso, Marco ^a   Giugni, Enrico ^a   Mortini, Pietro ^a   Acerno, Stefania ^a   Giovanelli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Antiandrogens; Hormone therapy; Pituitary neoplasm; Prostate cancer

Indexed keywords

FLUTAMIDE; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLINDNESS; CASE REPORT; HUMAN; HYPOPHYSIS TUMOR; MALE; METASTASIS; NEUROLOGIC DISEASE; OPHTHALMOPLEGIA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FLUTAMIDE; HUMANS; LEUPROLIDE; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM METASTASIS; PITUITARY NEOPLASMS; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0030848846     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970901)32:4<241::AID-PROS3>3.0.CO;2-M     Document Type: Article

References (13)

1. Max MB, Deck MDF, Rottenberg DA: Pituitary metastasis: Incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology 1981;31:998-1002.
2. Smulders J, Smets W: Les metastases des carcinomes mammaires. Frequence des metastases hypophysaires. Bull Assoc Fr Cancer 1960;47:434-456.
3. Branch CL, Laws ER: Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 1987;65:469-174.
4. Catane R, Kaufman J, West C, Merrin C, Tsukada Y, Murphy GP: Brain metastasis from prostatic carcinoma. Cancer 1976;38: 2583-2587.
5. Matsumoto I, Furusato M, Inomata I, Wada T, Aizawa S: Prostatic cancer presenting as metastatic adenocarcinoma of sphenoid sinus. Acta Pathol Jpn 1986;36:1753-1756.
6. Couldwell WT, Chandrasoma PT, Weiss MH: Pituitary gland metastasis from adenocarcinoma of the prostate. J Neurosurg 1989;71:138-140.
7. Perloff JJ, LeMar HJ, Reddy BW, Carter TE, McDermott MT: Metastatic adenocarcinoma of the prostate manifested as a sellar tumor. South Med J 1992;85:1140-1141.
8. Houck WA, Olson KB, Horton J: Clinical features of tumor metastasis to the pituitary. Cancer 1970;26:656-659.
9. Ransom DT, Dinapoli RP, Richardson RL: Cranial nerve lesions due to base of the skull metastases in prostate carcinoma. Cancer 1990;65:586-589.
10. Soloway MS, Ishikawa S, Zwang RV, Todd B: Prognostic factors in patients with advanced prostate cancer. Urology 1989;33:53-56.
11. Crawford ED, DeAntonio EP, Labrie F, Schroder FH, Geller J: Therapeutic controversies. Endocrine therapy of prostate cancer: Optimal form and appropriate timing. J Clin Endocrinol Metab 1995;80:1062-1078.
12. Castaldo JE, Bernat JL, Meier FA, Schned AR: Intracranial metastases due to prostatic carcinoma. Cancer 1983;52:1739-1747.
13. Anderson DF, Afshar F, Toma N: Metastatic prostatic adenocarcinoma presenting as complete ophthalmoplegia from pituitary apoplexy. Br J Ophthalmol 1994;78:315-316.